Bristol Myers Squibb Co financial data

Symbol
BMY, CELG-RI on NYSE, BMYMP on OTC
Industry
Pharmaceutical Preparations
Location
Route 206 And Province Line Road, Princeton, NJ
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 119 % -11.9%
Quick Ratio 12.5 % +5.65%
Debt-to-equity 467 % +127%
Return On Equity -53.3 % -303%
Return On Assets -9.42 % -210%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.03B shares +0.35%
Entity Public Float 84.2B USD -37%
Common Stock, Value, Issued 292M USD 0%
Weighted Average Number of Shares Outstanding, Basic 2.03B shares -2.03%
Weighted Average Number of Shares Outstanding, Diluted 2.03B shares -2.45%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 48.3B USD +7.32%
Research and Development Expense 11.2B USD +20%
Costs and Expenses 56.7B USD +55%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.85B USD -166%
Income Tax Expense (Benefit) 554M USD +38.5%
Net Income (Loss) Attributable to Parent -8.95B USD -212%
Earnings Per Share, Basic -4.41 USD/shares -214%
Earnings Per Share, Diluted -4.41 USD/shares -214%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.3B USD -9.75%
Marketable Securities, Current 171M USD -86.8%
Accounts Receivable, after Allowance for Credit Loss, Current 9.01B USD +1.46%
Inventory, Net 2.56B USD -3.94%
Other Assets, Current 5.62B USD -4.91%
Assets, Current 29.8B USD -6.26%
Deferred Income Tax Assets, Net 4.24B USD +53%
Property, Plant and Equipment, Net 7.14B USD +7.37%
Operating Lease, Right-of-Use Asset 1.22B USD -11.9%
Intangible Assets, Net (Excluding Goodwill) 23.3B USD -13.9%
Goodwill 21.7B USD +2.6%
Other Assets, Noncurrent 6.11B USD +13.7%
Assets 92.6B USD -2.69%
Accounts Payable, Current 3.6B USD +10.5%
Employee-related Liabilities, Current 1.69B USD +31.2%
Liabilities, Current 23.8B USD +6.79%
Accrued Income Taxes, Noncurrent 1.49B USD -54.7%
Deferred Income Tax Liabilities, Net 369M USD +9.17%
Operating Lease, Liability, Noncurrent 1.37B USD -10.5%
Other Liabilities, Noncurrent 4.47B USD -30.4%
Liabilities 76.2B USD +16.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.24B USD +19.9%
Retained Earnings (Accumulated Deficit) 14.9B USD -48.2%
Stockholders' Equity Attributable to Parent 16.3B USD -44.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 16.4B USD -44.4%
Liabilities and Equity 92.6B USD -2.69%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.83B USD -4.58%
Net Cash Provided by (Used in) Financing Activities 14.6B USD
Net Cash Provided by (Used in) Investing Activities -19.6B USD -9242%
Common Stock, Shares Authorized 4.5B shares 0%
Common Stock, Shares, Issued 2.9B shares 0%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.19B USD -689%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.3B USD -10.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 308M USD -4.94%
Deferred Tax Assets, Valuation Allowance 929M USD +21.6%
Deferred Tax Assets, Gross 9.37B USD +15.7%
Operating Lease, Liability 1.55B USD -8.33%
Depreciation 651M USD +6.55%
Payments to Acquire Property, Plant, and Equipment 284M USD +2.16%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -8.64B USD -211%
Lessee, Operating Lease, Liability, to be Paid 1.92B USD -9.81%
Property, Plant and Equipment, Gross 12.1B USD +5.56%
Operating Lease, Liability, Current 181M USD +11.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 235M USD -0.42%
Lessee, Operating Lease, Liability, to be Paid, Year One 255M USD +13.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +25%
Deferred Income Tax Expense (Benefit) -711M USD -29.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 370M USD -15.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 208M USD -1.42%
Preferred Stock, Shares Issued 2.87K shares -2.88%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 1.43B USD -25.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 188M USD -8.29%
Additional Paid in Capital 46B USD +0.74%
Preferred Stock, Shares Outstanding 2.87K shares -2.88%
Amortization of Intangible Assets 9B USD -2.17%
Depreciation, Depletion and Amortization 2.53B USD +4.24%
Deferred Tax Assets, Net of Valuation Allowance 8.44B USD +15.1%
Share-based Payment Arrangement, Expense 507M USD -2.12%
Interest Expense 1.3B USD +9.13%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%